Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Am J Transplant. 2018 Feb 2;18(6):1340–1350. doi: 10.1111/ajt.14639

TABLE 3.

GROUP CHARACTERISTICS MEDIAN
CREATININE
RANGE MEDIAN DAYS
TERMINAL
RANGE
C PURE CAMR: NO NK NO CD3 1.5 1.1–4.6 815 477–2023
D MIXED: CAMR + NK FCGR3A 2.8 0.9–5.1 386 71–1379
E MIXED:CAMR + NK FCGR3A > CD3 3 1.0–8.0 470 75–838
F MIXED: CAMR + NK + CD3 2.8 0.8–8.7 378 110–930
G STRONG TCMR: SOME NK 3 1.3–14 173 58–282
H WEAKER TCMR: SOME NK 1.2 1.0–3.9 164 69–910

Terminal graft survival for Group C is significantly different from Groups D, E, or F: FDRPV < 0.01

Terminal graft survivals and creatinines for Groups G and H are signficantly different: FDRPV < 0.03